3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Pre-Eclampsia
1
Lymphoma, Follicular
1
Interventions
Carboplatin
6
anlotinib
5
lenvatinib
4
Oxaliplatin
4
Immune Checkpoint Inhibitors
4
Cisplatin
4
tislelizumab
3
sintilimab
3
Fluorouracil
3
Capecitabine
3
venetoclax
2
Rosuvastatin Calcium
2
Prednisone
2
Megestrol Acetate
2
Leucovorin
2
Drug Therapy
2
Dexmedetomidine
2
Dexamethasone
2
Cyclophosphamide
2
Bevacizumab
2
Aspirin
2
zanubrutinib
1
xiaojin wan
1
trastuzumab deruxtecan
1
trametinib
1
tocilizumab
1
testosterone 17 beta-cypionate
1
tenofovir alafenamide
1
telitacicept
1
taxane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Not yet recruiting
×
Furosemide
×
Clear all
NCT07167862
2026-01-23
PPPOCUS
University of California, Irvine
Phase 4
Not yet recruiting
96 enrolled